Inhibiting Cyclin-Dependent Kinase / Cyclin Activity for the Treatment of Cancer and Cardiovascular Disease
Carmen Ivorra(Instituto de Biomedicina de Valencia), Vicente Andrés(Centro de Investigación en Red en Enfermedades Cardiovasculares), H. Samyn, Antonio Díez‐Juan(Igenomix), Silvia M. Sanz‐González(Universitat de València), Célio José de Castro(Instituto de Medicina y Biología Experimental de Cuyo), Masataka Edo
Cited by 10
Related Papers
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
|Science|2017|1.5k
Telomere Biology and Cardiovascular Disease
|Circulation Research|2006|241
A mechanism of AP-1 suppression through interaction of c-Fos with lamin A/C
|Genes & Development|2006|221
Defective Extracellular Pyrophosphate Metabolism Promotes Vascular Calcification in a Mouse Model of Hutchinson-Gilford Progeria Syndrome That Is Ameliorated on Pyrophosphate Treatment
|Circulation|2013|211
Fast regulation of AP-1 activity through interaction of lamin A/C, ERK1/2, and c-Fos at the nuclear envelope
|The Journal of Cell Biology|2008|173